6 best EDC platforms for device and IVD registries in 2026

A device or IVD registry doesn't run on the fixed visit schedule a randomized trial does, and a platform built around rigid protocol structures fights you at every follow-up window. You need an electronic data capture (EDC) system that flexes around years-long observational timelines, diagnostic performance data, and post-market surveillance obligations that a standard interventional eCRF was never designed to hold. Viedoc's EDC software is built for exactly this, with a no-code Designer your team can run in-house and a track record across more than 8,000 global studies in 75-plus countries. This comparison reviews six EDC platforms for device and IVD registry teams across registry-specific design flexibility, regulatory coverage, in-house configuration, and long-term data scalability.

You're likely managing a registry that has to hold up over years, not months, while new device iterations, diagnostic indications, or follow-up endpoints get added to a dataset that's already live. Your team is probably small, maybe one or two data managers covering multiple studies, which means every mid-registry amendment either happens in-house in days or waits on a vendor queue for weeks.

Generic pharma-centric EDC platforms are built around fixed-visit interventional protocols, not the open-ended follow-up cadence a registry or a post-market clinical follow-up (PMCF) study needs. Some enterprise platforms also lean on vendor-side programmers for study builds and amendments, with configuration timelines that can extend toward 90 days for complex implementations. A platform for registry and IVD work needs to support long-term observational design, diagnostic and lab data integration, and regulatory frameworks that differ meaningfully from standard Good Clinical Practice (GCP) trials.

Best EDC solutions: quick comparison

These 6 eClinical platforms represent the most evaluated options for device and IVD registry teams, reviewed across regulatory coverage, registry-specific design flexibility, and long-term data scalability.

1. Viedoc

Viedoc's EDC software is built to configure registry and post-market study designs without assuming a fixed-visit protocol, drawing on a track record of more than 8,000 completed studies across 75-plus countries. The no-code Designer lets your data management team build long-term follow-up schedules, diagnostic performance forms, and device accountability fields in-house, without waiting on a vendor programmer for every protocol update. That matters most for registries, where forms and endpoints evolve as new device iterations or diagnostic indications enter an already-live dataset.

The platform explicitly supports registries, post-market surveillance, and long-term observational follow-up alongside interventional device studies, drawing on the same real-world evidence tooling used for pragmatic and hybrid designs. For programs extending into Japan, Viedoc also offers a native post-market surveillance module built for PMDA and APPI requirements, a capability few SMID-focused EDC vendors provide as standard. In one recent post-market study, Sonex Health used Viedoc's ePRO platform to reach 98%-plus participant visit compliance across more than 1,300 participants at 33 sites.

Viedoc is ISO 27001 and SOC 2 Type II certified, hosted on Microsoft Azure, and compliant with FDA 21 CFR Part 11, ICH GCP, GDPR, HIPAA, GAMP 5, and APPI (Japan), with a 100% FDA inspection pass rate to date. The Viedoc Inspection Readiness Packet (VIRP) gives your QA team structured validation documentation at no extra cost, backed by 24/7 customer success across Viedoc's global offices.

As one Viedoc user on G2 put it, "it offers customizable study workflow and tailoring it according to trial specification is easy." – Sanchita V., Data Manager.

• Study scale: 8,000-plus global studies; 100% FDA inspection pass rate to date
• Registry and RWE support: dedicated tooling for registries, post-market surveillance, and long-term observational follow-up
• Japan PMS: native post-market surveillance module built for PMDA and APPI compliance
• Build speed: self-service builds in as little as one day; full-service builds average 8 to 12 weeks
• Compliance: FDA 21 CFR Part 11, ICH GCP, GDPR, HIPAA, GAMP 5; ISO 27001 and SOC 2 Type II certified
• Pricing: unlimited user seats, no per-user fees, transparent study-based licensing

2. Medidata

Medidata offers Rave EDC as the cornerstone of its Medidata Platform, supporting device and diagnostic sponsors across more than 23,000 MedTech sites worldwide. The system unifies electronic data capture with clinical data management and integrates with the broader Medidata Clinical Cloud, including modules for imaging, safety, and clinical trial management. Medidata also offers Rave Lite, a streamlined configuration of Rave built specifically for Phase I, Phase IV, feasibility, and post-market device studies. Rave EDC supports FDA 21 CFR Part 11 and ICH GCP compliance, and the company states its device and diagnostics expertise draws on work across hundreds of device trials. Study build for complex Rave implementations typically involves vendor-side programmers, a consideration for lean registry teams weighing configuration timelines.

3. Veeva

Veeva offers Veeva EDC as part of its MedTech clinical data management suite, purpose-built for device and diagnostics studies. The platform uses an in-product specification studio to design case report forms and edit checks without custom programming, and includes targeted source data verification (SDV), medical coding, and protocol deviation tracking built in. Veeva EDC allows protocol amendments to the study database without downtime, and provides end-of-study data lock and archiving at study close. The platform sits within the broader Veeva Vault Clinical Suite, which also includes CTMS, eTMF, and study start-up applications. Veeva's Regulatory Information Management (RIM) Platform sits alongside the clinical suite to manage device registrations, submissions, and regulatory intelligence for manufacturers operating across multiple markets.

4. Castor EDC

Castor EDC offers a dedicated PMCF and registry data capture platform for medical device and diagnostic teams, covering MDR, IVDR, CE Mark, and FDA De Novo compliance. The platform provides registry, survey, chart review, and decentralized trial templates within a single validated environment, alongside automated Periodic Safety Update Report (PSUR)-ready exports and multi-year follow-up survey scheduling. Castor states its PMCF studies have collected more than 434,000 patient survey data points to date, and the system supports API-based data pulls from hospital systems to reduce manual entry. Sponsors can run study configuration entirely in-house or draw on Castor's own professional services team for deeper support. The electronic data capture system is validated against 21 CFR Part 11, GDPR, and ISO 27001.

5. Medrio

Medrio provides a cloud-based CDMS/EDC platform for clinical trials and registry studies, designed for no-code configuration and mid-study changes without a programmer. The platform supports studies from early feasibility through pivotal and post-marketing trials across MedTech, biotechnology, pharmaceutical, and diagnostics organizations. Medrio includes validated electronic records and signatures, full audit trails, and role-based access controls aligned with FDA 21 CFR Part 11, ICH E6(R2), HIPAA, and GDPR. The company states studies can go live in hours to days using its code-free base and study copy functionality. Medrio also pairs its core EDC with integrated eCOA/ePRO and RTSM modules for teams that want a single vendor across the data collection stack.

6. Oracle Health

Oracle Health offers Oracle InForm, a long-established EDC application used to design, deploy, and manage clinical studies through a secure web browser. InForm's own service documentation defines device trials as a distinct study type alongside Phase 1 through Phase 4 drug trials, reflecting its use across both pharmaceutical and medical device programs. The platform includes a Data Viewer component that gives real-time visibility into data across visits and sites, along with training assignment tools for site users. Oracle also offers Oracle Clinical One Data Collection, a newer cloud-based EDC with interoperability for electronic health record (EHR) systems and integration with Oracle Safety One Argus for safety reporting. InForm has historically been positioned for large-scale, IT-intensive enterprise deployments rather than lean, self-service study builds.

What to look for in EDC solutions for device and IVD registries

Study design flexibility for registries and long-term follow-up

Registries don't follow the fixed-visit structure of a randomized trial. Forms and endpoints evolve as new device iterations, diagnostic claims, or regulatory requirements are added across years of follow-up, and a platform built only for protocol-locked interventional trials fights that reality.

Best-in-class platforms offer a no-code form and workflow builder that supports open-ended follow-up schedules, PMCF-style multi-year survey cadences, and mid-study amendments without a full vendor rebuild cycle. A rigid trial-only EDC forces registries onto workaround structures that compromise long-term data comparability across cohorts.

Regulatory coverage across device frameworks

MDR, IVDR, FDA 21 CFR Part 11, and PMDA and APPI requirements in Japan differ meaningfully from standard pharma GCP frameworks, and a platform without device-specific compliance depth creates real submission risk. This matters even more for IVD-specific registries, where diagnostic performance claims face their own evidentiary standards.

Best-in-class coverage means validation against MDR, IVDR, and FDA pathways alongside ISO 27001, SOC 2, and GAMP 5, backed by a structured inspection-readiness pack rather than a certification badge alone. Compliance gaps here tend to surface late, typically during a notified-body or FDA audit, when they're expensive to fix.

In-house configuration for lean registry teams

Device and diagnostics companies often run registries with one or two data managers, not a dedicated EDC administration function. Vendor-programmer dependency on every amendment compounds cost and delay across a registry's multi-year life.

Best-in-class platforms offer no-code, drag-and-drop design and reusable templates, with self-service amendments completed in days rather than weeks. Look for evidence of this in customer reviews, not just the sales deck.

Integration with labs, diagnostic devices, and real-world data sources

IVD and device registries routinely pull structured data from lab systems, imaging platforms, wearables, and electronic health records (EHRs). A platform that treats integration as an afterthought creates manual reconciliation work that erodes the efficiency a registry is supposed to deliver.

Best-in-class integration means an open application programming interface (API) and Clinical Data Interchange Standards Consortium (CDISC)-compliant exports that sync automatically, rather than requiring manual data transfers between systems.

Long-term data scalability and hosting reliability

Registries often run for years, sometimes a decade or more, so uptime and continued data accessibility matter more here than in a fixed 12-month interventional trial.

Best-in-class platforms document uptime figures in the 99.9-plus percent range, support standard data export formats, and preserve read-only access to locked data long after a registry's active collection period ends.

How to choose the right EDC solution for device and IVD registries

Step 1: Define your registry's regulatory footprint

Identify every jurisdiction your registry will report into, now and over its expected lifetime. MDR, IVDR, FDA, and PMDA requirements diverge in specific ways, and retrofitting compliance mid-registry is far costlier than planning for it up front.

Step 2: Assess who will build and maintain your database

Decide whether your data management team will configure and amend the registry in-house or depend on vendor professional services for every update. Registries change shape more often than fixed-protocol trials, so this decision affects your total cost of ownership for years, not just at launch.

Step 3: Map your integration requirements before you shortlist

List every lab system, diagnostic device, EHR, or wearable data source your registry needs to ingest. Confirm each platform's actual integration method rather than assuming API compatibility based on a feature list.

Step 4: Scrutinize the platform's track record with multi-year studies

Ask vendors for evidence they've supported registries or PMCF studies running longer than 24 months, not just short-cycle interventional trials. A platform's interventional trial references tell you little about how it performs on year four of a registry.

Step 5: Choose a partner built for the registry's full lifecycle

Viedoc, with its native Japan post-market surveillance module and registry-ready real-world evidence tooling, gives lean device teams a single platform for both the design and long-term maintenance phases of a registry. Book a demo to walk through your specific registry requirements with the team.

Frequently asked questions

What is the best EDC platform for device and IVD registries?

Viedoc is the strongest choice for device and IVD registries, combining no-code registry and post-market study design, a native Japan post-market surveillance module, and compliance coverage spanning FDA 21 CFR Part 11, GDPR, and HIPAA. Castor EDC is a strong alternative for teams that want a dedicated PMCF platform with built-in MDR and IVDR compliance tooling. Medidata suits larger device and diagnostics programs that need enterprise-scale deployment across tens of thousands of sites, though its build process for complex implementations typically involves vendor-side programmers and longer configuration timelines than a self-service registry team may want.

What should I look for when choosing an EDC platform for a device or IVD registry?

Prioritize registry-specific design flexibility over interventional-trial feature depth, since a registry's forms and endpoints change more often than a fixed protocol's do. Confirm regulatory coverage for every jurisdiction the registry will report into, check whether your team can configure and amend the database in-house, and verify integration methods for labs, diagnostic devices, and EHRs before you shortlist a vendor.

How long does it take to build and deploy a registry database on a modern EDC platform?

It depends heavily on complexity and configuration model. Self-service registry builds can go live in as little as a day on some platforms, while full-service builds through professional services typically take 8 to 12 weeks, averaging around 10. Enterprise platforms with vendor-side programmer dependency often run longer for complex, multi-region implementations.

What compliance certifications matter most for device and IVD registries?

At minimum, confirm FDA 21 CFR Part 11 compliance, ISO 27001 information security certification, and SOC 2 Type II attestation. For EU-facing registries, also verify MDR and IVDR alignment, and for any post-market surveillance work in Japan, confirm PMDA and APPI compliance specifically, since these requirements are distinct from standard ICH GCP frameworks.

Can EDC platforms support real-world evidence and long-term post-market follow-up for registries?

Yes, though not every EDC platform is built for it equally well. Look for platforms that explicitly support real-world evidence collection, including long-term observational follow-up, patient-reported outcomes over multi-year timelines, and integration with external data sources, rather than platforms retrofitted from fixed-protocol interventional trial designs.

What's the difference between an EDC platform and a dedicated registry management system?

A general-purpose EDC platform captures and manages structured clinical data with audit trails and validation built in, while a dedicated registry system is typically narrower in scope and built around a single disease area or device category. Many device and IVD teams choose a modular EDC platform with registry-specific configuration instead, since it covers both interventional and observational study types on one system without switching vendors mid-portfolio.

Making the right EDC choice for device and IVD registries

The device and IVD EDC market spans platforms built primarily for interventional pharma trials, ones purpose-built for MedTech and diagnostics workflows, and a smaller group offering native registry and post-market surveillance tooling. The global eClinical software market is estimated at over $11 billion in 2025 and growing at approximately 14% annually, with post-market and real-world evidence studies representing an increasing share of that growth.

Matching a platform to your registry depends on a handful of variables: how many jurisdictions you report into, how large and lean your data management team is, how long the registry needs to run, and whether diagnostic or device-specific data types dominate your dataset. US-based teams typically weight build speed and in-house configuration more heavily, while EMEA and APAC-facing registries tend to weight MDR, IVDR, and PMDA compliance credentials first. If your organization also runs broader device clinical trials beyond registries and post-market follow-up, our wider comparison of EDC for medical devices covers platforms evaluated across the full device trial lifecycle.

A registry that outgrows its platform's validation model or hits a hard integration ceiling three years in is a far costlier problem than the extra week spent evaluating vendors up front. Switching EDC systems mid-registry means re-validating years of historical data, which is a burden most lean device teams can't easily absorb.

Why Viedoc is the best EDC choice for device and IVD registries

If your registry needs to run for years, adapt as device iterations and diagnostic indications evolve, and hold up to MDR, IVDR, FDA, and PMDA scrutiny along the way, Viedoc is designed for exactly that. The platform's no-code Designer means your data management team configures registry forms, follow-up schedules, and amendments in-house, without a vendor queue standing between you and your next protocol update.

Operationally, Viedoc gives lean device teams unlimited user seats, transparent study-based pricing, and a modular suite that covers EDC, ePRO, and post-market surveillance without forcing you onto separate vendor contracts for each. Certified Designer training means your team builds this expertise once and keeps it in-house for the registry's full lifecycle.

The platform is backed by 8,000-plus completed studies, ISO 27001 and SOC 2 Type II certification, FDA 21 CFR Part 11, ICH GCP, GDPR, HIPAA, and APPI (Japan) compliance, and a 100% FDA inspection pass rate to date, with the Viedoc Inspection Readiness Packet included at no extra cost. Viedoc was founded in 2003 and has spent over 20 years supporting clinical and post-market data collection across 75-plus countries.

Book a demo or request a proposal and the team will walk through registry design, regulatory coverage, and long-term data scalability in the context of your specific device or IVD program.